Alzamend Neuro (ALZN) Retained Earnings (2020 - 2026)

Alzamend Neuro has disclosed Retained Earnings across 7 years of filings, most recently posting $68.0 million for Q2 2026.

• In Q2 2026, Retained Earnings rose 8.86% year-over-year to $68.0 million; the TTM figure through Apr 2026 stood at $68.0 million (up 8.86% YoY), while the FY2026 annual figure was $68.0 million, up 8.86% from the prior year.
• Retained Earnings came in at $68.0 million for Q2 2026 at Alzamend Neuro, up from $66.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $68.0 million in Q2 2026 to a low of -$55.0 million in Q3 2024.
• Average Retained Earnings over 5 years is $42.5 million, with a median of $61.2 million recorded in 2023.
• Year-over-year, Retained Earnings plunged 188.19% in 2024 and jumped 221.07% in 2025.
• Over 5 years, Retained Earnings stood at $59.0 million in 2022, then increased by 6.27% to $62.7 million in 2023, then slipped by 4.05% to $60.2 million in 2024, then climbed by 10.72% to $66.6 million in 2025, then increased by 2.14% to $68.0 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $68.0 million in Q2 2026, $66.6 million in Q1 2026, and $66.6 million in Q4 2025.